Kite Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Kite Pharma, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $548.61 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2017-08-08
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $548.61M.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $346.43M.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $117.25M.
- 2016-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $170.42M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2017-06-30 | $548.61M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $346.43M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $117.25M 10-Q · filed 2017-05-08 | |
| 2016-09-30 | $170.42M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $143.49M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $130.87M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $211.10M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $193.21M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $237.46M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $226.01M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $64.70M 10-Q · filed 2015-11-12 | $231.86M 10-K · filed 2015-03-26 |
| 2014-09-30 | $99.34B 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $103.40M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $1.98M 10-K · filed 2015-03-26 | $1.98M 10-Q · filed 2014-08-14 |